nVerses Capital’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-29,090
Closed -$134K – 149
2026
Q2
$134K Buy
+29,090
New +$110K 0.21% 225

Other funds holding MGNX

nVerses Capital's MGNX Position: Q3 2026 in Review

nVerses Capital sold out of MacroGenics (MGNX) in Q3 2026, closing a stake of 29,090 shares — an estimated $134K sold.

nVerses Capital first reported a position in MGNX in Q2 2026 and held it in 1 quarter. The position peaked at $134K in Q2 2026. 129 funds tracked by Wall St. Rank hold MGNX as of Q3 2026.

  • nVerses Capital reported no remaining MacroGenics position as of Q3 2026 after selling out during the quarter.
  • nVerses Capital sold 29,090 MacroGenics shares in Q3 2026, an estimated $134K.
  • nVerses Capital first reported a position in MacroGenics in Q2 2026 and held it in 1 quarter.
  • nVerses Capital's MacroGenics position peaked at $134K in Q2 2026.
  • 129 funds tracked by Wall St. Rank held MacroGenics as of Q3 2026.

Based on nVerses Capital's 13F filing for Q3 2026.